pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - todos los demás productos terapéuticos - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
sparkle v 5% sodium fluoride varnish, marca: crosstex.
e.b. pareja lecaros s.a. -
clinpro 5% sodium fluoride white varnish.
3m peru s.a. -
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - infecciones por vih - antivirales para uso sistémico - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
thorsødium
lopsÖnn - antibioticos quimioterapicos y otros - bovinos;
sodium hyaluronate 3% w/v with chondroitin sulphate sodium 4% w/v ophthalmic solution, marca: aurocoat plus
asg inversiones e.i.r.l. -
sodium hyaluronate 2% w/v with chondroitin sulphate sodium 2% w/v ophthalmic solution, marca: aurocoat
asg inversiones e.i.r.l. -
sodium chondroitin sulphate & sodium hyaluronate ophthalmic solution, marca: supracoat plus
inversiones medicas san martin s.a.c. -
sodium hyaluronate ophthalmic solution 1.0%, 1.4%, 1.6%, 1.8%, 2.0%, 3.0%, marca: sida-visc
mot s.a. -
sodium hyaluronate ophthalmic solution 1% bio hyalur 1ml pfs, sodium hyaluronate ophthalmic solution 2.4% bio hyalur hv 1ml pfs,
taga international s.a.c. -